| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 11/25/2010 | US20100298212 Modified Insulin Polypeptides and Their Uses |
| 11/25/2010 | US20100298201 Peptidomimetic macrocycles with improved properties |
| 11/25/2010 | US20100298200 Compounds and assays for controlling Wnt activity |
| 11/25/2010 | US20100297268 Agent for increasing blood adiponectin quantity |
| 11/25/2010 | US20100297267 Compositions for diabetes treatment and prophylaxis |
| 11/25/2010 | US20100297253 Treatment of diabetes with milk protein hydrolysate |
| 11/25/2010 | US20100297249 Enhancement of the efficacy of therapeutic proteins |
| 11/25/2010 | US20100297227 Pharmaceutical composition comprising at least one active agent and a binder, which swells in an acidic media |
| 11/25/2010 | US20100297221 pharmaceutical composition of tacrolimus |
| 11/25/2010 | US20100297219 Methods and Compositions for Modifying Apolipoprotein B mRNA Editing |
| 11/25/2010 | US20100297209 Solvent/polymer solutions as suspension vehicles |
| 11/25/2010 | US20100297135 Epitope for neutralizing antibodies |
| 11/25/2010 | US20100297111 Nanobodies against tumor necrosis factor-alpha |
| 11/25/2010 | US20100297106 Pharmaceutical Formulations |
| 11/25/2010 | US20100297105 Administering antisense oligonucleotides complementary to human apolipoprotein b |
| 11/25/2010 | US20100297097 Compounds |
| 11/25/2010 | US20100297094 Therapy or prevention of diseases with cells or cell supernatant |
| 11/25/2010 | US20100297077 Novel aryl potassium channel blockers and uses thereof |
| 11/25/2010 | US20100297066 Biodegradable peptide releasing polymers |
| 11/25/2010 | US20100297054 1,2,3-triazole derivatives for use as stearoyl-coa desaturase inhibitors |
| 11/25/2010 | US20100297035 Thiazole Amides, Imidazole Amides and Related Analogues |
| 11/25/2010 | US20100297031 Orodispersible tablets |
| 11/25/2010 | US20100297020 Phosphorylated and phosphonated pyrone analogs for therapeutic treatment |
| 11/25/2010 | US20100297011 Isolated peptides and uses thereof |
| 11/25/2010 | DE112008002948T5 Extraktzubereitung von Opuntia ficus indica Extract preparation of Opuntia ficus indica |
| 11/25/2010 | CA2763016A1 Targeting micrornas for metabolic disorders |
| 11/25/2010 | CA2762939A1 Self-emulsifying composition of .omega.3 fatty acid |
| 11/25/2010 | CA2762813A1 Use of inhibitors of zdhhc2 activity for modulation of adipogenesis |
| 11/24/2010 | EP2253705A1 Use of inhibitors of Zdhhc2 activity for modulation of adipogenesis |
| 11/24/2010 | EP2253642A1 Polypeptides, cDNAs encoding the same and utilization thereof |
| 11/24/2010 | EP2253630A1 Heterocyclic compound and use thereof |
| 11/24/2010 | EP2253328A1 Cycloalkyl inhibitors of potassium channel function |
| 11/24/2010 | EP2253327A1 Pharmaceutical composition containing a compound having angiotensin II antagonistic activity in combination with another compound |
| 11/24/2010 | EP2253315A1 Alkoxyphenylpropanoic acid derivatives |
| 11/24/2010 | EP2253314A2 Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2 |
| 11/24/2010 | EP2253221A1 Semi-finished product of edible mushrooms, method of its production and use |
| 11/24/2010 | EP2252613A1 Compounds and compositions as modulators of gpr119 activity |
| 11/24/2010 | EP2252599A1 Triazole amide derivatives for use in therapy |
| 11/24/2010 | EP2252598A2 1,3-oxazepan-2-one and 1,3-diazepan-2-one inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| 11/24/2010 | EP2252592A1 Arylchalcogeno-arylalkyl-substituted imidazolidine-2,4-diones, method for the production thereof, medicaments containing said compounds and use thereof |
| 11/24/2010 | EP2252591A1 Aryl-substituted imidazolidine-2,4-diones, method for the production thereof, medicaments containing said compounds and use thereof |
| 11/24/2010 | EP2252586A1 Compounds and compositions as modulators of gpr119 activity |
| 11/24/2010 | EP2252582A2 Pyrrolidine derivatives |
| 11/24/2010 | EP2252289A1 Combination therapy comprising sglt inhibitors and dpp4 inhibitors |
| 11/24/2010 | EP2252283A1 Synthetic triterpenoids and methods of use in the treatment of disease |
| 11/24/2010 | EP2252167A1 High protein liquid enteral nutritional composition |
| 11/24/2010 | EP2091531B1 Phenyl substituted maleimides as medicaments for blocking degenerative tissue damages by inhibiting mpt |
| 11/24/2010 | EP2089031B1 Reduction of overweight or obesity |
| 11/24/2010 | EP2019823B1 Benzamide glucokinase activators |
| 11/24/2010 | EP1785137B1 Remedy for hyperlipemia |
| 11/24/2010 | EP1638970B1 Pyrid (2, 1-a) - isoquinoline derivatives as dpp-iv inhibitors |
| 11/24/2010 | EP1603917B1 Immunomodulating heterocyclic compounds |
| 11/24/2010 | EP1549156B1 Denatured carob flour (dcf) with a low content of soluble tannins and sugars, meant for human consumption and process to obtain it |
| 11/24/2010 | EP1546375B1 Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 11/24/2010 | EP1539739B1 Piperidinyl compounds that selectively bind integrins |
| 11/24/2010 | EP1497285B1 Benzoxazinone-derived compounds, their preparation und use as medicaments |
| 11/24/2010 | EP1474387B1 Derivatives of alpha-phenylthiocarboxylic and alpha-phenyloxy-carboxylic acids useful for the treatment of diseases responding to ppar alpha activation |
| 11/24/2010 | EP1438418B1 Stem cells of the islets of langerhans and their use in treating diabetes mellitus |
| 11/24/2010 | EP1370260B1 Azoles as malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 11/24/2010 | CN1985848B Compound vitamin and mineral preparation for prenatal taking |
| 11/24/2010 | CN1942181B Tablet containing branched chain amino acid and process for producing the same |
| 11/24/2010 | CN1880304B Triamide-substituted indoles, benzofuranes and benzothiophenes |
| 11/24/2010 | CN101896483A Glucokinase activators and pharmaceutical compositions containing the same as an active ingredient |
| 11/24/2010 | CN101896481A Pyrimidyl indoline compound |
| 11/24/2010 | CN101896473A Inhibitors of stearoyl-coa desaturase |
| 11/24/2010 | CN101896472A HEDGEHOG pathway antagonists and therapeutic applications thereof |
| 11/24/2010 | CN101896465A Cannabinoid receptor modulators |
| 11/24/2010 | CN101896192A A method of treating cachexia with the removal or inactivation of macrophage inhibitory cytokine-1 |
| 11/24/2010 | CN101896187A Therapeutic agent for ulcer |
| 11/24/2010 | CN101896174A Trans-clomiphene for metabolic syndrome |
| 11/24/2010 | CN101892249A Pufa polyketide synthase systems and uses thereof |
| 11/24/2010 | CN101892226A Small interfering RNA (siRNA) for restraining ACC gene expression of human adipocyte and expression vector and application thereof |
| 11/24/2010 | CN101891831A Method for preparing stable slow-digestion starch |
| 11/24/2010 | CN101891823A Exendin-4 and analog fusion protein thereof |
| 11/24/2010 | CN101891817A Monoclonal antibody capable of preventing high mobility group box-1 (HMGB-1) and application thereof |
| 11/24/2010 | CN101891747A Compound capable of inhibiting phosphodiesterase type 5 and preparation method |
| 11/24/2010 | CN101891706A 3,4-dihydrobenzo[f][1,4]thiazepine compound or salts of same and medical use of same |
| 11/24/2010 | CN101891680A Modulators of atp-binding cassette transporters |
| 11/24/2010 | CN101891618A 2-[(2,3,4-trialkoxy-6-acyl) phenyl] acetic ester as well as preparation method and application thereof |
| 11/24/2010 | CN101890172A Application of S100A16 gene in preparing drug for treating obesity |
| 11/24/2010 | CN101890167A Conveniently implantable sustained release drug compositions |
| 11/24/2010 | CN101890166A Combination of organic compounds |
| 11/24/2010 | CN101890165A Composition for lowering blood pressure and application thereof |
| 11/24/2010 | CN101890163A Use of anti-tnfalpha antibodies and another drug |
| 11/24/2010 | CN101890145A Medicament for treating diabetes and preparation thereof |
| 11/24/2010 | CN101890124A Chinese medicinal health care product with blood fat reduction effect |
| 11/24/2010 | CN101890098A Medicament for treating type II diabetic cardiopathy and preparation method thereof |
| 11/24/2010 | CN101890097A Chinese medicinal composite biopolypeptide composition |
| 11/24/2010 | CN101890094A Health care product for assisting in reducing blood fat and preparation method thereof |
| 11/24/2010 | CN101890073A Chinese medicinal composition for preventing and treating hyperlipaemia and fatty liver and preparation method thereof |
| 11/24/2010 | CN101890063A Chinese medicament for reducing blood sugar and preparation method thereof |
| 11/24/2010 | CN101890060A Preparation for nourishing pancreas islet, reducing blood sugar and regulating blood pressure and blood fat and preparation method thereof |
| 11/24/2010 | CN101890058A Health-care bio-chip based on nano-taxus and preparation method thereof |
| 11/24/2010 | CN101890053A Composite Chinese medicinal herb pure natural high-calcium preparation series |
| 11/24/2010 | CN101890046A Composition with heart rate reducing properties |
| 11/24/2010 | CN101890036A Application of astragaloside |
| 11/24/2010 | CN101890035A Application of trifolin |
| 11/24/2010 | CN101890026A Water soluble vitamin D2 and calcium colloid injection medicinal composition |
| 11/24/2010 | CN101890017A Medicament composition containing sibutramine and stanin fat-reducing medicament and application thereof |
| 11/24/2010 | CN101890013A Pitavastatin calcium composition stabilized by using alkaline reagent and preparation method thereof |